Cardiol Therapeutics Inc - Class A — Quarterly Financial Data (NASDAQ:CRDL) | MetaTrader

Open full chart

Financials

Overview Estratto Conto Statistics Dividends

Quarterly Annual

Dividends per share — — Dividend yield % — — Payout ratio % — —

Notizie

Cardiol Therapeutics publishes phase II myocarditis study results

Cardiol Therapeutics deposita accordo di sottoscrizione e contratto di warrant

Cardiol Therapeutics files underwriting agreement and warrant indenture

Cardiol Therapeutics annuncia un posizionamento privato di 13,5 milioni di dollari

Cardiol Therapeutics announces $13.5 million private placement

Cardiol Therapeutics annuncia finanziamento garantito da 13,5 milioni di dollari

Cardiol Therapeutics announces $13.5 million bought deal financing

Cardiol Therapeutics raggiunge il 50% di arruolamento nello studio sulla pericardite ricorrente

Cardiol Therapeutics reaches 50% enrollment in recurrent pericarditis trial

H.C. Wainwright riconferma rating Buy per Cardiol Therapeutics con target di $9

H.C. Wainwright reaffirms Buy rating on Cardiol Therapeutics stock at $9 target

Why MongoDB Shares Are Trading Higher By Over 22%; Here Are 20 Stocks Moving Premarket - Ambitions Enterprise Mgmt (NASDAQ:AHMA), American Bitcoin (NASDAQ:ABTC)